Results 131 to 140 of about 21,179 (232)

Degradation of enrofloxacin by Fe0 activated PDS

Scientific Reports
Abstract In this paper, the effect of zero-valent iron (Fe0) activated persulfate (PDS) on the removal of enrofloxacin (ENR) was investigated, and the effect and mechanism were analyzed by exploring the effects of Fe0 concentration, PDS concentration, pH, and the influence of anion and aqueous matrix on the removal of ENR by the Fe0/PDS system.
Yaru Zhang, Zhenguo Li, Wenlong Bi, Bo Sun, Huanhuan Pei, Junmei Qin, Fenwu Liu   +6 more
openaire   +3 more sources

Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and intramuscular administrations in sheep

, 1996
Objective - To evaluate the pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after administrations of enrofloxacin in sheep. Design - Crossover study performed by IV and IM administrations of 2.5 mg of enrofloxacin/kg of body weight to 2
SOLDANI, GIULIO, MENGOZZI G., INTORRE, LUIGI, INTORRE L., SOLDANI G., MENGOZZI, GRAZIA, BERTINI, Simone, Bertini S   +7 more
core  

Nanobodies: A Promising Toolkit for Diagnostic Applications

SmartMat, Volume 7, Issue 3, June 2026.
This review focuses on camelid‐derived nanobodies (VHHs) and explains how their small size and high stability support robust diagnostic design. Applications across ELISA, lateral flow assays, and PET/SPECT imaging are summarized, along with clinical progress such as caplacizumab.
Wei Wu, Abid Ali, Li Sun, Jiahao Hu, Lina Hameed, Saba Shafi, Ali Raza, Khuzin Dinislam, Wenjing Xing, Long Rong, Jie Lin, Jian Ma   +11 more
wiley   +1 more source

Food–Drug Interactions: Effect of Propolis on the Pharmacokinetics of Enrofloxacin and Its Active Metabolite Ciprofloxacin in Rabbits

Pharmaceuticals
Propolis is a natural resinous substance produced by honeybees that has many biological activities. For thousands of years, it has been widely used as a dietary supplement and traditional medicine to treat a variety of ailments due to its antimicrobial ...
Ali Sorucu, Cengiz Gokbulut, Busra Aslan Akyol, Osman Bulut   +3 more
doaj   +1 more source

Experimental Study on Withdraw of Enrofloxacin From Milk

, 1993
Enrofloxacin was given to clinically healty six holstein dairy cows at a dosage of 2, 5mg / k * g of body weight by IM as only dose. Milk samples were taken from cows 24th, 48th, 72th, 96th and 120th hours after drug administration and before ...
Oğuz, Halis, Baş, A. Levent, Traş, Bünyamin   +2 more
core  

Ellagic Acid Attenuates Oxidative Stress and Improves Cardiovascular Function Following Myocardial Infarction in Ovariectomized Rats

Journal of Cellular and Molecular Medicine, Volume 30, Issue 12, June 2026.
ABSTRACT Oestrogen deficiency increases oxidative stress and reduces nitric oxide (NO) bioavailability, contributing to cardiac fibrosis following myocardial infarction (MI). This study investigated whether ellagic acid (EA), a natural antioxidant, attenuates post‐MI cardiac fibrosis in ovariectomized rats by reducing oxidative stress and pro ...
Laís Lopes Gonçalves, Ildernandes Vieira Alves, Erika Ferreira Nicoli, Deiviany Santana Santos Lima, Virginia Soares Lemos, A. Augusto Peluso, Patrick Wander Endlich, Simone Alves de Almeida, Glaucia Rodrigues de Abreu   +8 more
wiley   +1 more source

Mechanisms of enrofloxacin antibiotic resistance in zoonotic E. coli

, 2013
Uropathogenic Escherichia coli strain (UPEC) represents the most common cause of urinary tract infections that could affect both animals and humans.
P. Roncada, V. Greco, J. Nally, M. Drigo, A. Urbani, C. Piras, A. Soggiu, L. Bonizzi, P.A. Martino   +8 more
core  

Impact of enrofloxacin on the human intestinal microbiota revealed by comparative molecular analysis

, 2012
The indigenous human intestinal microbiota could be disrupted by residues of antibiotics in foods as well as therapeutically administered antibiotics to humans. These disruptions may lead to adverse health outcomes.
Kim, Jong Nam, Yoon, Seok-Hwan, Kim, Bong-Soo, Cerniglia, Carl E., Chun, Jongsik   +4 more
core   +1 more source

Effect of enrofloxacin treatment on plasma endotoxin during bovine Escherichia coli mastitis.

, 2002
Objective and design: To investigate the effect of enrofloxacin on endotoxin resorption during bovine Escherichia coli mastitis. Animals: 12 healthy early postpartum Holstein cows.
Massart-Leën, A. M., Burvenich, Christian Paul G., Dosogne, H., VAN LOON, J, van Loon, J., Burvenich, Christian Paul G.DI118010003469340000-0002-1156-0981F3D2FDB0-F0ED-11E1-A9DE-61C894A0A6B4, Dosogne, Hilde, Meyer, Evelyne, Dosogne, Hilde8010011178806EAFB5A6-B25E-11E6-B104-2D2FD0AF0289, Meyer, E., Meyer, EvelyneDI070019842774668010007390750000-0002-7066-8255F4730512-F0ED-11E1-A9DE-61C894A0A6B4, Burvenich, C., MASSART-LEEN, AM, Sturk, A., STURK, A   +14 more
core   +1 more source

Effect of enrofloxacin on digoxin clearance and steady-state serum concentrations in dogs

, 1991
The effect of enrofloxacin on the oral clearance and steady-state concentrations of digoxin in serum was evaluated in dogs. Digoxin was administered orally to six healthy adult Beagle dogs following a multiple-dose regimen of 0.0625 mg every 12 h for 23 ...

core